APA (7th ed.) Citation

M, T., D, K., CJ, D., C, P., KE, B., TY, O., . . . RC, S. (2025). A window trial in metastatic pancreatic ductal adenocarcinoma reveals resistance mechanisms to targeting the KRAS-MEK pathway. BioRxiv : the preprint server for biology. https://doi.org/10.64898/2025.12.12.693851

Chicago Style (17th ed.) Citation

M, Tsuda, et al. "A Window Trial in Metastatic Pancreatic Ductal Adenocarcinoma Reveals Resistance Mechanisms to Targeting the KRAS-MEK Pathway." BioRxiv : The Preprint Server for Biology 2025. https://doi.org/10.64898/2025.12.12.693851.

MLA (9th ed.) Citation

M, Tsuda, et al. "A Window Trial in Metastatic Pancreatic Ductal Adenocarcinoma Reveals Resistance Mechanisms to Targeting the KRAS-MEK Pathway." BioRxiv : The Preprint Server for Biology, 2025, https://doi.org/10.64898/2025.12.12.693851.